期刊文献+

黑睛排斥汤防治大鼠高危角膜移植免疫排斥反应的机理研究 被引量:1

Mechanism of Heijing Paichi Decoction in preventing immune rejection on high-risk corneal transplantation rats
下载PDF
导出
摘要 目的探讨黒睛排斥汤在大鼠高危角膜移植免疫排斥反应中作用的机理。方法角膜缝线法诱导角膜新生血管,建立大鼠高危角膜移植模型,随机分为A组(模型对照),B组(灌服黒睛排斥汤4 g/(kg.d)),C组(灌服黒睛排斥汤4 g/(kg.d)+CsA 10 mg/(kg.d))。行封闭群大鼠SD-Wistar组间同种异体全板层角膜移植,观察植片存活状况;应用流式细胞分析,免疫荧光组织化学等方法对受体局部和全身免疫状态机制进行检测。结果 1.角膜植片存活时间:A组(10.38±1.69)d,B组(13.00±2.03)d,C组(22.50±3.07)d,3组比较差异有统计学意义(P<0.01)。2.外周血淋巴细胞CD4+和CD8+亚群:术后7 d,CD4+,CD8+,CD4+/CD8+各组之间比较均无明显差别(P>0.05);术后14 d,C组CD4+、CD4+/CD8+与A组比较明显降低(P<0.05);术后21 d,B、C组CD4+、CD4+/CD8+与A组比较明显降低(P<0.05),但各组CD8+比较无明显差异(P>0.05)。3.ConA诱导的脾淋巴细胞的增殖:B组、C组脾T淋巴细胞的增殖被明显抑制,与A组比较差异有统计学意义(P<0.01),其中以C组更为明显。结论黒睛排斥汤对高危角膜移植排斥反应模型大鼠术后免疫排斥反应的抑制作用主要是通过抑制T淋巴细胞的增殖来实现的。 OBJECTIVE To study the action mechanism of Heijing Paichi Decoction on the immunological rejection after high-risk corneal transplantation. METHODS Established homogeneity variant SD-Wister rat's high-risk corneal transplantation model. The model was established by suture method including corneal neoangio-genesis and the whole shelf corneal transplantation. Randomly divided into group A-C. Group A : negative control, Group B : Heijing Paichi Decoction (4g/kg·d), Group C : Heijing Paichi Decoction (4g/kg- d) combined with CsA ( 10mg/kg·d). We observed the survival status of the allograft and the local and systemic immune status in the recip-ients using immunofluorescence histochemistry and flow cytometry. RESULTS The implant's survival time, group A was the shortest, (10.38±1.69d) and group C was the longest (22.5±3.07d). On the 1st week, the expression of CD4+ molecule and CD8+ molecule and the ratio of CD4+/CD8+ had no obvious difference in every group (P〉0.05) ; The expression of CD4+ molecule in experimental B and C was down-regulated on the 2nd week, and it had a significant difference compared with the control group (P〈0.05). And on the 3rd week, the expression of CD4+ molecule and the ratio of CD4+/CD8+ in experimental B and C was down-regulated compared with the control (P〈0.05). There was no difference between control and experimental group on CD8+ expression (P〉0.05). Group B and C had signifi- cant down-regulation compared with A (P〈0.01), especially C. The MTT was inhibited in group B and C compared with group A. CONCLUSIONS Heijing Paiehi Decoction has certain effect on preventing high-risk corneal transplantation immune rejection in rat model, which was mainly by inhibiting T lymphocyte proliferation to fulfill.
出处 《中国中医眼科杂志》 2011年第6期316-321,共6页 China Journal of Chinese Ophthalmology
关键词 高危角膜移植 黑睛排斥汤 免疫排斥 high-risk corneal transplantation Heijing Paichi Decoction immune rejection
  • 相关文献

参考文献17

  • 1Harnrah P.High-risk Penetrating Kerato Plasty[J].Arch Soe Es P Oftalmol,2005,80 (1):5-7.
  • 2Williams KA,Coster DJ.Penetrating corneal tranplantation in the inbred rat:a new model[J].Invest Ophthalmol Vis.Sci,1985,26(1):23-30.
  • 3Larkin DFP,Calder VL,L ightman SL.Identification and characterization of cells infiltarating the graftand aqueous humour in ratcornealal lograft rejection[J].Clin Exp Immunol 1997,107 (2):381-391.
  • 4李志杰,彭广华,李辰.眼免疫性疾病[M].郑州:河南科学技术出版社,1995:133-136.
  • 5Niederkorn JY.Immunology and immunomodulation of corneal transplantation[J]Intern Rcv Immnnol,2002,21 (2-3):173-196.
  • 6Dana MR,Qian Y,Hamrah P.Twenty-five-year panorama of corneal immunology[J].Cornea,2000,19 (5):625-643.
  • 7Dallman MJ.Cytokies and transplantation:Th1/Th2 regulation of the immune response to solid organ transplants in the adult[J].Curr Opin Immunol,1995,7 (5):632-638.
  • 8史伟云,谢立信.CD4和CD8基因敲除鼠行穿透性角膜移植术后免疫排斥特征的研究[J].中华眼科杂志,2005,41(4):350-354. 被引量:20
  • 9Joo CK,Pepose JS,Stuart PM.T-cell mediated responses in a murine m odel of orthotopic corneal transplantation[J].Invest Ophthalmol Vis Sci.1995,36(8):1530-1540.
  • 10He YG,Ross J,Niederkorn JY.Promotion of murine orthotopiccorneal allograft survival by systemic administration of anti-CD4 monoclonal antibody[J].Invest Ophthalmol Vis Sci,1991,32 (10):2723-2728.

二级参考文献54

共引文献51

同被引文献21

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部